Glucocortıcoıds: As A Clınıcıan We Use Much, We Know Less

Do We Know What We Do not Know? A Response to Celine Bonnet

Vitamin D: the more we know, the less we know.

Over the last 20 years there have been numerous studies, including NHANES III (the National Health and Nutrition Examination Survey III), the Women’s Health Study, and the Nurses’ Health Study, showing an association between decreased 25-hydroxyvitamin D [25(OH)D] concentrations in blood and the risks of cardiovascular disease, stroke, cancer, fractures, and mortality (see the Supplemental Read...

Superior Capsule Reconstruction: What Do We Know?

The management of irreparable rotator cuff tears remains challenging. Since its introduction by Mihata in 2012, superiorcapsule reconstruction (SCR) has grown in popularity at an astonishingly rapid rate. The aim of this article is to providea comprehensive review of the available literature, in order to highlight what has so far been published on SCR,covering all aspects including biomechanica...

The more we know , the less we agree ∗

Stylized facts on the increased trading volume around public announcements in various financial markets give the impression that public information releases increase disagreement among traders. However, it is widespread opinion in the economic literature that under Bayesian updating and common priors, public information cannot cause divergence of opinion. We show that this is true only under sp...

Nonhost resistance: how much do we know?

Nonhost disease resistance is the most common form of disease resistance exhibited by plants against the majority of potentially pathogenic microorganisms. Recently, several components of nonhost disease resistance have been identified. Nonhost resistance exhibited against bacteria, fungi and oomycetes can be of two types. Type I nonhost resistance does not produce any visible symptoms whereas ...